Aurobindo Pharma trades higher on the BSE

28 Jun 2024 Evaluate

Aurobindo Pharma is currently trading at Rs. 1208.65, up by 19.90 points or 1.67% from its previous closing of Rs. 1188.75 on the BSE.

The scrip opened at Rs. 1197.40 and has touched a high and low of Rs. 1210.70 and Rs. 1192.00 respectively. So far 23962 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1292.15 on 07-Jun-2024 and a 52 week low of Rs. 709.00 on 04-Jul-2023.

Last one week high and low of the scrip stood at Rs. 1245.00 and Rs. 1180.80 respectively. The current market cap of the company is Rs. 70664.20 crore.

The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 41.30% and 6.87% respectively.

Aurobindo Pharma’s step-down subsidiary -- Eugia SEZ has received Establishment Inspection Report for Telangana facility, classifying the facility as Voluntary Action Indicated (VAI). The U.S. Food and Drug Administration (USFDA) had conducted an inspection at the injectable facility of Eugia SEZ, situated at Polepally Village, Jadcherla Mandal, Mahaboobnagar District, Telangana, from February 19, 2024 to February 29, 2024. 

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1240.70 -14.70 (-1.17%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.